Role of toxin ζ and starvation responses in the sensitivity to antimicrobials by Tabone, Mariangela et al.
Role of Toxin f and Starvation Responses in the
Sensitivity to Antimicrobials
Mariangela Tabone., Virginia S. Lioy.¤a, Silvia Ayora, Cristina Macho´n¤b, Juan C. Alonso*
Departamento de Biotecnologı´a Microbiana, Centro Nacional de Biotecnologı´a, (CNB-CSIC), Madrid, Spain
Abstract
A fraction of otherwise antimicrobial-sensitive Bacillus subtilis cells, called persisters, are phenotypically tolerant of
antimicrobial treatment. We report that, independently of B. subtilis’ growth phase, transient f toxin expression induces a
dormant state and alters cellular responses so that cells are more sensitive to antimicrobials with different modes of action.
This outcome is modulated by fine tuning (p)ppGpp and GTP levels: i) in the presence of low ‘‘dysregulated’’ (p)ppGpp
levels (as in relA2 cells) hyper-tolerance to both toxin and antimicrobials was observed; ii) physiological or low (p)ppGpp
levels (as in the wild-type, sasA2, sasB2 and relA2 sasA2 context) show a normal toxin and antimicrobial tolerance; and iii)
lower levels (in relA2 sasB2) or absence of (p)ppGpp (in the relA2 sasA2 sasB2 context), in concert with elevated GTP levels,
potentiate the efficacy of both toxin and antimicrobial action, rendering tolerance vulnerable to eradication.
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Introduction
The human and economical costs of antimicrobial ‘‘resistance’’
exceed J 1.5-billon each year [1]. New antimicrobial ‘‘resistance’’
challenges continue to evolve and spread worldwide; very
important among them is the trait known as non-inheritable
phenotypic tolerance, also called persistence [2]. The molecular
bases of antimicrobial persistence are under active investigation in
Proteobacteria. The studies of proteobacterial cells with this trait,
called persisters, have identified multiple genes involved in this
phenomenon, and several of these are components of toxin-
antitoxin (TA) modules. It is well documented that expression of
proteobacterial type II toxins which halt protein synthesis (e.g.,
HipA, RelE, MazF) in high-density slow- or non-growing cells
shuts down cell proliferation in a large fraction of cells (dormancy)
and increase the rate of persisters, resulting in multidrug tolerance
(MDT) [3–11]. The causes of antimicrobial persistence are poorly
understood in bacteria of the Firmicutes phylum. Since Proteo-
bacteria (e.g., Escherichia coli) and Firmicutes (e.g., Bacillus subtilis)
phyla diverged over one billion years ago, it is expected that the
analysis of Firmicutes toxins and the comparison with those of
Proteobacteria would contribute to our understanding of antimi-
crobial persistence in a broader range of bacteria.
Toxin f and RelE are the most ubiquitous toxins in nature [12].
The target of these two toxins differ: RelE halts protein synthesis
by cleaving mRNA in the ribosomal A site, whereas toxin f
phosphorylates the 39-OH group of the amino sugar moiety of
UDP-N-acetylglucosamine (UNAG), leading to its conversion to
unreactive UNAG-3P and thereby affecting cell wall synthesis
[13–15]. Toxin f is widely presented in Firmicutes, therefore the
role of this toxin should be analyzed to gain insight into the
molecular bases of antimicrobial persistence in bacteria of this
phylum. The plasmid- or chromosomal-borne f-e (also termed
PezT-A) TA complex consists of two monomeric long-living f
toxins (half-life ,80 min) separated by a dimeric short-living e (e2)
antitoxin (half-life ,16 min) [16,17]. Conditions that prevent ef
gene expression or promote e2 antitoxin degradation, by a host-
encoded protease(s), permit f toxin to act freely to block cell
proliferation in the large majority of the cells [16–20]. At early
times of expression, free wt f or its short-living variant (fY83C,
half-life ,28 min) triggers an heterogeneous set of protective
responses and alters the expression of ,2% of total E. coli or B.
subtilis genes rather than showing a bactericidal behavior [17,20].
Within the first 15 min, fY83C toxin increases RelA expression,
decreases the GTP pool and reduces lipid metabolism and DNA
replication without apparent alteration of the B. subtilis proteome
[17,20]. Within the 15–60 min interval, fY83C expression reduces
the synthesis of macromolecules, decreases ATP levels, increases
the alarmone guanosine (penta)tetraphosphate ([p]ppGpp) pool
size, and alters the membrane potential of B. subtilis cells [20].
Within the 60–90 min, fY83C inhibits cell wall biosynthesis
[15,20]. Finally, expression of fY83C for longer periods (120–
240 min) leads to a fraction (20–30%) of the population stained
with propidium iodide (suggesting cell death), and a subpopulation
of B. subtilis cells exhibits non-inheritable toxin tolerance (1–
561025 survivals) [17,20]. However, fY83C toxin expression for
longer periods of time (8–16 h) reduces toxin tolerance of B. subtilis
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cells to very low levels (2–661028 colony forming units, CFUs)
[19].
The interaction of the e2 antitoxin with the f toxin inactivate the
toxic effect of the latter. The structure of the inactive fe2f complex
bound to its target, UNAG, is known [13–15]. The molecular
mechanisms by which f toxin induces reversible cessation of B.
subtilis proliferation (protective dormancy) and by which a minor
subpopulation of toxin-sensitive cells becomes tolerant of transient
f toxin action are poorly understood. Transient f toxin expression
triggers the synthesis of (p)ppGpp [20], but cells that cannot
activate the responses to starvation (e.g., in the null relA [DrelA]
context) show an increase in the fraction of cells tolerant of the f
toxin [20] and of antimicrobials (hyper-tolerance) (this work).
Conversely, overexpression of the HipA7 toxin, which also triggers
ppGpp synthesis, increases the rate of Ampicillin (Amp) persis-
tence, but the absence of RelA in this bacterium diminishes the
high persistent phenotype in hipA7 mutant E. coli cells [21,22]. It is
worth mentioning that the global transcriptional response to
starvation and the physiological role of (p)ppGpp in E. coli cells do
not explain the mechanism of action of (p)ppGpp and/or GTP
(GDP) in B. subtilis ([SI] Annex S1 in File S1) [23,24]. Therefore f
toxin might be a good candidate to address the mechanism(s) of
antimicrobial tolerance and their potential link with the variations
in the (p)ppGpp and/or GTP pool in Firmicutes.
In B. subtilis, active starvation responses, as the stringent
response induced by amino acid starvation, switch the cell
metabolism from the growth mode to the survival mode, resulting
in slow growth, high (p)ppGpp and low GTP (or GDP) levels (see
SI Annex S1 in file S1 and Figure S1 in file S2). B. subtilis, as with
many other species of the Firmicutes Phylum, possesses three
enzymes that control the cellular pool of (p)ppGpp. The
bifunctional synthase-hydrolase RelA is the major modulator of
the intracellular levels of (p)ppGpp [25–27]. In addition, two
secondary monofunctional small alarmone synthases (termed
SasA, RelP, Sas1 or YwaC and SasB, RelQ, Sas2 or YjbM)
contribute to accumulation of unknown (p)ppGpp levels, and fine-
tune the (p)ppGpp levels during homeostatic growth in the wt
context (Figure S1 in file S1) [25,27–29]. The rapid accumulation
of (p)ppGpp during stress conditions is mainly dependent on the
RelA enzyme [27,28]. In the absence of RelA, there is also a poor
growth phenotype and this could be due to ‘‘dysregulated’’
undetectable (p)ppGpp levels, by the contribution of the mono-
functional SasA and/or SasB synthases (SI Annex S1 in file S1).
In this study, we report that f-mediated inhibition of cell
proliferation alters the cell physiology, leading to increased
multidrug sensitivity (MDS) rather than MDT. Subsequent
expression of the e2 antitoxin specifically reverses f-induced
inhibition of cell proliferation (dormancy), but not the sensitivity to
different antimicrobials. Our results suggest that f-induced
dormancy per se is not sufficient to trigger MDT at least under
the experimental conditions used. Fluctuations in (p)ppGpp and/
or GTP levels, however, lead to a different response to f toxin and
antimicrobials. Hyper-tolerance of toxin and antimicrobial action
was observed in the relA2 context (‘‘dysregulated’’ undetectable
(p)ppGpp levels). An artificial decrease of (p)ppGpp levels, by
transient exposure to limiting relacin concentrations, reduced
hyper-tolerance of relA2 cells to levels similar to relA+ or sasA2
sasB2 cells. Lower or absent [p]ppGpp and elevated GTP levels (as
occur in the relA2 sasB2 or relA2 sasA2 sasB2 context) sensitize
bacterial cells to antimicrobial and toxin action. An artificial
decrease of GTP levels, by transient exposure to decoyinine,
reduces cells killing in these backgrounds.
Materials and Methods
Bacterial strains and media
The bacterial strains used in this study are described in Table S1
in file S2. To express f toxin, two inducible systems, integrated as a
unique copy in the chromosomal amy locus, were used to mimic
the native levels of the toxin [17,20]. Strains containing the fY83C
toxin variant cassette consist of the fY83C gene transcribed from a
xylose (Xyl)-dependent promoter (Pxyl) under the control of XylR
repressor and the cat gene conferring resistance to chloramphen-
icol (CamR) (Table S1 in file S2) [17,20]. In the absence of Xyl,
fY83C toxin expression did not affect cell viability [20].
Strains containing the wt f toxin cassette consist of the wt f gene
transcribed from the hyper-spank promoter (Phsp) under the control
of the LacI repressor, and the spc gene conferring resistance to
spectinomycin (lacI-Phspf spc) (Table S1 in file S2) [20]. The strains
containing the lacI-Phspf spc cassette also carry in addition the
pCB799-borne e gene (transcribed from Pxyl under the control of
XylR repressor) [20]. Low Xyl concentrations were needed to
construct the strains containing the wt f gene under Phsp
transcriptional control [20]. Addition of low Xyl concentration
(0.005%) allowed low levels of the e2 antitoxin expressed from
pCB799 plasmid, which titrated out basal levels of f toxin and
avoided genetic rearrangements [20].
B. subtilis DmazF chromosomal DNA obtained from C. Condon
(IBPC, France) was used to transform BG687 (control strain,
which lacks the fY83C toxin cassette) and BG689 (contains the
fY83C toxin cassette) competent cells with selection for erythro-
mycin (Ery) resistance, to produce strains BG1241 and BG1243,
respectively (Table S1 in file S2). SPP1 stock phages amplified in
BG687 or BG689 cells were used to transduce the control or the
fY83C toxin cassette with selection for CamR into wt, single
(DrelA, DsasA, DsasB), double (DsasA DsasB, DrelA DsasB, DrelA
DsasA) and triple mutants (DsasA DsasB DrelA) obtained from F.
Kawamura (RU, Japan) to produce strains BG1202, BG1203,
BG1205, BG1207, BG1211, BG1209, BG1301 and BG1213,
respectively (Table S1 in file S2).
Except for DrelA derived mutants, the BG214 isogenic strains
were grown in S7 minimal medium (MMS7) supplemented with
the required amino acid (methionine and tryptophan) at 50 mg/ml
[17]. The isogenic DrelA strains show a ‘‘phenotypic auxotrophy’’
for valine, leucine, isoleucine and threonine, and were also
supplemented with these amino acids (at 25 mg/ml) [17,20]. The
S7 medium supplemented with the required amino acids was also
termed MMS7.
Expression levels of the fY83C or f toxin
Depending on the expression system, to moderate-density cells
(,56107 cells/ml) growing at 37uC in MMS7, Xyl (0.5%) or
IPTG (1 mM) was added. Cells were taken at different times after
Xyl or IPTG, centrifuged, resuspended in buffer A (50 mM Tris
HCl [pH 7.5], 150 mM NaCl, 5% glycerol) and lysed by
sonication as described [20]. For Western blotting, extracts
containing equal concentrations of protein were separated on
10% SDS-PAGE. Blots were probed with rabbit polyclonal
antibodies raised against f, which were obtained using standard
techniques [16]. Previously it was reported that the level of wt f
toxin in moderate- and high-density cells expressed from its native
context, where the e2 antitoxin was also present, was ,1,400 f
monomers/cell [16]. Induction of the xylR-PXylAfY83C cassette,
by addition of 0.5% Xyl to exponentially growing BG689 cells
rendered low levels of induction. Expression increased to a plateau
with a fY83C toxin concentration of 300624 toxin monomers/
cell at ,3 to 5 min, and the steady-state level of the toxin
Toxin f Enhances Efficacy of Antimicrobial Treatment
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remained for at least 240 min as previously described (this work)
[20]. Expression of the xylR-PXylAfY83C cassette, by addition of
0.5% Xyl in the BG1203 background, increased fY83C to a
plateau of 340640 toxin monomers/cell, and the steady-state level
of the toxin remained for at least 240 min in these strains.
Induction in the lacI-Phspf spc cassette, by addition of 1 mM
IPTG to exponentially growing BG1125 cells [20], increased f
toxin to a plateau concentration of 1,7006125 wt f monomers/
cell and the steady-state level of f remained for at least 240 min. In
these strains, the presence of 0.005% Xyl, necessary to avoid
genomic rearrangements, accounted for low levels of e2 antitoxin
expression [,150 wt e2 antitoxin/cell]. These toxin concentra-
tions are comparable to the level of wt f toxin in its native context
(,1,400 f monomers/cell) (this work) [16]. Similar results were
observed when the levels of fluorescence of wt f fused to GFP (f-
GFP) were measured in bulk, in the presence of e2 antitoxin [19].
The level of f-GFP fluorescence was relatively homogeneous,
however, they vary significantly in a small cell fraction among the
individual cells of an otherwise identical population (data not
shown). In ,1% of total cells the f-GFP levels are significantly
higher (2- to 3-fold) than average [18,19].
Assay for studies on the effect of f expression on the
viability of antimicrobial treated cells
The minimal inhibitory concentration (MIC) of the different
antimicrobials tested was estimated by exposing 1–36106 cells/ml
for 16 h at 37uC in MMS7 with shaking (240 rpm) to different
concentrations of the antimicrobials employed. Except for Ery,
which was used at 4 times the MIC (20 mg/ml), the remaining
antimicrobials were used at twice the MIC (ampicillin [Amp],
3 mg/ml; ciprofloxacin [Cip], 0.4 mg/ml; and triclosan [Tri],
3 mg/ml). Under conditions of no toxin expression (i.e, in the
absence of inducer), the presence (BG689, BG1125, BG1145,
BG1202) of the fY83C or f gene does not affect the MIC (data not
shown).
Cells were grown in MMS7 to mid-exponential phase (,56107
cells/ml) or to early stationary phase in MMS7 and then diluted
into pre-warmed fresh MMS7 to ,16109 or ,16106 cells/ml.
Expression of the toxin was induced either with 1 mM IPTG (wt f
toxin cassette) or with 0.5% Xyl (fY83C toxin cassette) and the
antimicrobial was added. After addition of Xyl/IPTG and/or
antimicrobial, at 120 or 240 min, the cells were centrifuged and
re-suspended with fresh LB medium to remove the inductor (Xyl/
IPTG) or the antimicrobial, and the corresponding dilutions were
plated on LB agar plates containing glucose (which switches off
fY83C expression) or on LB agar plates containing Xyl to express
the e2 antitoxin (f toxin cassette), unless otherwise indicated. The
survival rate, derived from the number of CFUs obtained in a
given condition relative to the CFUs of the non-induced/non-
antimicrobial treated control is documented. Except DrelA and
DsasA DsasB DrelA strains, cells grew in MMS7 with a doubling
time of 50–60 min. The doubling time of DrelA and DsasA DsasB
DrelA increased 1.4- to 1.8-fold when compared to the wt strain.
All plates were incubated for 20 h at 37uC, except plates were
synthase mutant strains were spread, which were incubated for
40 h at 37uC.
Limiting relacin (1 mM) or decoyinine (100 mg/ml) concentra-
tions were added to early-exponential phase (OD560 = 0.1) cells,
and cells were allowed to grow to mid-exponential phase
(OD560 = 0.4, ,56107 cells/ml) in MMS7. Expression of the
toxin was induced with 0.5% Xyl and Amp was added. At
120 min, the cells were centrifuged and re-suspended in fresh LB
to remove the antimicrobial and the inducer and the correspond-
ing dilutions were plated on LB agar plates.
Results and Discussion
Experimental design
Antimicrobial persisters (also called tolerants), which might arise
through a mechanism analogous to that of toxin tolerance, is a
natural multimodal system where a subpopulation of bacterial cells
enters a transient-non-growth state that confers tolerance to
antimicrobials [7,11]. The exit from persistence has been linked to
the switch between alternative physiological states with cells
forming colonies upon plating in a rich medium in the absence of
the antimicrobial [11]. At least four types of mechanisms for
antimicrobial persistence have been proposed. First, persister
bacteria are those that at the time of exposure to the antimicrobials
have their targets inactive, as in growth-arrested cells or in a
‘‘protected’’ stage of the cell cycle [11]. Second, toxin action leads
to a high frequency of phenotypic persistence to different
antimicrobials; leading to MDT [30]. Third, persisters are those
able to adapt rapidly to antimicrobial treatment by switching on/
off genes linked to general stress responses [31]. Fourth,
persistence is a programmed, epigenetic phenomenon with a
genetic basis that has evolved to allow prokaryotic organisms to
survive changing environments [30,32]. To test the first two
hypotheses we compared the effects of different antimicrobials and
controlled f toxin expression in exponentially growing wt B. subtilis
cells, versus stationary phase cells (Figure 1, Figure 2, Figure 3). To
test the last two hypotheses, the starvation control mechanisms
were disrupted (Figure 4, Figure 5).
Expression of fY83C toxin sensitizes cells to
antimicrobials during exponential growth
Previously it was shown that low levels of expression of a short-
living variant of the f toxin (fY83C), 300 monomers/cell (see
Materials and methods), induced dormancy and a condition
similar to the effects of amino acid starvation (increasing synthesis
of (p)ppGpp, and decreased GTP pool) in the majority of the cells
[20]. To test whether toxin-induced dormancy make cells
transiently refractory to antimicrobials with different modes of
action, moderate-density (,56107 cells/ml) exponentially growing
cells in MMS7 was used. As already shown, transient expression of
the fY83C toxin under this condition, by addition of 0.5% Xyl (see
Materials and Methods), produced typical biphasic survival
kinetics with an initial rapid decrease in CFUs in the first
60 min and a tolerant subpopulation with stable CFUs between 60
and 300 min [20], so that for simplicity the data at 120 and
240 min are presented (see Figure 1, Figure 2, Figure 3). A
subpopulation of cells were tolerant of fY83C toxin action, and
they were quantified upon serial dilutions and plating in LB agar
(2–561025 survivals, Figure 1). Alternatively, in this small
subpopulation of tolerant cells the fY83C toxin might not be
expressed. To test this hypothesis fY83C toxin expression was
induced for longer periods, and the ratio of tolerant cells was
measured. The expression of the fY83C toxin for 480 or 960 min
significantly reduced the tolerant fraction (4–661028 survivals,
data not shown). Similar results were obtained upon transient
expression of the wt f toxin for 480 min or longer times, and then
inducing the expression of the e2 antitoxin [17]. For this reason we
considered unlike that the small subpopulation of fY83C tolerant
cells are simply due to no expression of the toxin. Furthermore, a
fused f-GFP variant revealed that the level of toxin expression was
significantly homogeneous in the majority of the cells [19]. The
large majority of these tolerant cells did not genetically acquire
resistance to toxin action see [17].
Antimicrobials with different modes of action (bactericidal or
bacteriostatic) were selected: Amp inhibits cell wall biosynthesis,
Toxin f Enhances Efficacy of Antimicrobial Treatment
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Ery inhibits protein translation, Cip inhibits the ligase step of type
II topoisomerases, and Tri inhibits fatty acid biosynthesis and
triggers (p)ppGpp synthesis, among other targets [33–36]. A highly
significant variation was observed in persister fractions following
exposure to the different antimicrobials, implying that tolerance to
an antimicrobial depends on the precise manner in which the
antimicrobial acts, and perhaps on the specific mechanism by
which the persister phenotype is generated. As observed in Fig. 1A,
transient exposure to Amp, Ery or Cip decreased colony formation
rendering 261022 to 161024 survivals upon exposure to the
antimicrobial for 120 min. A similar ratio of persistence was
observed when the cells were exposed for 60 or 90 min (data not
shown). These cells exhibited phenotypic tolerance, because when
re-grown, they remained sensitive to the antimicrobial (data not
shown). The ratio of persister cells was strongly reduced, to 4–
861027 survivals, upon transient exposure to Tri for 120 min, and
was at the detection limit (,161027) upon exposure to this
antimicrobial for 240 min (Figure 1A and 1B). It is likely that
bacteria evolved different ways of persisting in response to different
antimicrobials, and that a lipid-targeting antimicrobial, such as
Tri, might reduce the acquisition of stochastic antimicrobial
tolerance in moderate-density exponentially growing cells.
To learn if fY83C toxin induction may favor the appearance of
tolerants, fY83C toxin was induced at the same time as cells were
treated with antimicrobials as described in Materials and Methods.
The abundance of fY83C (,300 monomers/cell), after Xyl
induction, was not significantly affected by the addition of an
antimicrobial (e.g., Amp) at least during the first 150 min when
compared with absence of the antimicrobial (see Materials and
methods). We observed that expression of fY83C toxin in the
presence of an antimicrobial for 120 or 240 min significantly
decreased colony formation compared to antimicrobial treatment
alone (Figure 1). A similar outcome was observed when dormancy
was first induced by addition of Xyl or the antimicrobial 30 min
Figure 1. Expression of fY83C toxin enhances the efficacy of different antimicrobials during exponential growth. BG689 cells were
grown in MMS7 at 37uC up to,56107 cells/ml, then 0.5% Xyl and/or an antimicrobial (AM) were added and the cultures were incubated for 120 min
A) or 240 min B) and then plated onto LB agar plates. The antimicrobials used were Amp, 3 mg/ml; Ery, 20 mg/ml; Cip, 4 mg/ml or Tri, 3 mg/ml. The
number of CFUs relative to the non-induced/non-AM treated control is shown. + and 2 denote the presence or the absence of the indicated
compound. Error bars show 95% confidence intervals of more than three independent experiments.
doi:10.1371/journal.pone.0086615.g001
Toxin f Enhances Efficacy of Antimicrobial Treatment
PLOS ONE | www.plosone.org 4 January 2014 | Volume 9 | Issue 1 | e86615
prior challenging by antimicrobial addition or fY83C toxin
expression, respectively (data not shown).
It is likely that: i) fY83C toxin arrest of cell growth per se does
not facilitate antimicrobial tolerance, at least with the antimicro-
bials tested; ii) f-induced and stochastic antimicrobial tolerance
may be a result of multiple distinct cellular physiologies within a
population; iii) the reduction of CFUs upon fY83C toxin
expression and antimicrobial addition may be due to the additive
effects of two independent killing mechanisms or fY83C toxin
expression may facilitate the exit of the persister state of different
antimicrobials; iv) the sensitization of cells to antimicrobial
addition and expression of the fY83C toxin supports the notion
that toxin tolerance cannot be attributed to low or lack of fY83C
expression.
Toxin fY83C and Ampicillin trigger different bacterial
responses
In the previous section we have shown that: i) expression of the
fY83C toxin, which at latter times inhibits cell wall biosynthesis
[15,20], reduced CFUs of exponentially growing cells ,50,000-
fold, and addition of Cip reduced CFUs ,10,000-fold; and ii)
expression of fY83C and addition of Cip showed an additive
effect, with ,761026 tolerant/ml (Figure 1). To test whether this
additive effect was due to the coordinated action of two cell
Figure 2. Expression of fY83C toxin enhances the efficacy of different antimicrobials in high- and low-density non-growing cells.
BG689 cells were grown in MMS7 at 37uC up to early stationary phase and diluted into fresh pre-warmed MMS7 to ,16109 cells/ml (A and B) or to
,16106 cells/ml (C and D). Then 0.5% Xyl and/or an AM were added and the cultures were incubated for 120 min (A and C) or 240 min (B and D). The
symbols, the plating conditions, and the antimicrobial concentrations are as described in Figure 1. Error bars show 95% confidence intervals of more
than three independent experiments.
doi:10.1371/journal.pone.0086615.g002
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proliferation inhibitors, fY83C toxin was replaced by another cell
wall inhibition (e.g., Amp) and cells were treated with both Amp
and Cip simultaneously. Moderate-density (,56107 cells/ml)
growing cells were transiently exposed to Amp and Cip or both for
120 min. As already observed, the addition of Cip decreased
CFUs ,10,000-fold, and the addition of Amp decreased CFU
,250-fold (Figure S2 in file S2). However, no additive effect was
observed, and transient treatment with both Cip and Amp for
120 min decreased CFUs .2,000-fold, which is lower reduction
than when cells were treated only with Cip (Figure S2 in file S2).
The data presented in Figure 1 and Figure S2 suggest that
expression of f toxin triggers specific bacterial responses that might
not parallel Amp or Cip responses.
A host-encoded toxin does not contribute to
toxin-mediated antimicrobial sensitivity
Previously it was shown that: i) in exponentially growing E. coli
cells successive deletion of the ten mRNase-encoding TA loci
progressively reduced the level of persisters, and deletion of the ten
toxins resulted in up to 200-fold reduction of Amp persisters; and
ii) ppGpp, which indirectly activates antitoxin degradation,
activates expression of host-encoded toxins that in turn induce
the persister-like phenotype [37]. The current knowledge suggests
that exponentially growing B. subtilis cells express only one
mRNase toxin, MazF (also called NdoA) [38,39]. To test whether
the increase in (p)ppGpp levels due to fY83C toxin expression, or
simply if the fY83C toxin activates expression of the host-encoded
MazF toxin, and this putative enhancement of mazF expression
Figure 3. Expression of the e2 antitoxin reverses the effect of f toxin, but does not increase MDT. (A and B) BG1125-borne f gene was
induced by the addition of 1 mM IPTG, and pCB799-borne e gene was induced by addition of Xyl. BG1125 cells were grown to ,56107 cells/ml in
MMS7 containing traces of Xyl (0.005%). Then, expression of f was induced and/or cells treated with an antimicrobial, and the cultures incubated for
120 min (A) or 240 min (B). At those times, samples were taken and plated on LB agar or on LB-0.5% Xyl plates to induce the expression of the e2
antitoxin. Expression of the e2 antitoxin reverses the effect of f toxin in non-growing cells. (C and D) BG1125 cells were grown in MMS7, containing
traces of Xyl (0.005%), up to early stationary phase, and diluted to ,16109 cells/ml. Then, expression of f was induced and/or cells treated with an
antimicrobial, and the cultures incubated for 120 min (C) or 240 min (D) with agitation at 37uC. At these times samples were taken and plated on LB
agar or LB-0.5% Xyl to induce the expression of the e2 antitoxin. The symbols, the plating conditions, and the antimicrobial concentrations were those
indicated in Figure 1. Error bars show 95% confidence intervals of more than three independent experiments.
doi:10.1371/journal.pone.0086615.g003
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contributes to antimicrobial persistence, strains bearing a null
mazF mutation (DmazF) and the fY83C toxin expression cassette
were constructed (Table S1 in file S2), and analyzed upon addition
of Xyl, Amp or both (Table 1). No increase in fY83C toxin
tolerance was observed in mazF+ exponentially growing cells when
compared with DmazF (1–261025 survivals) (Table 1).
The absence of MazF decreased Amp (26MIC) lethality by
,2-fold. Similarly, in a previous report it was shown that in B.
subtilis the absence of MazF decreased kanamycin (106MIC) and
moxifloxacin (166MIC) lethality by 10- to 15-fold [39]. When
moderate-density (,56107 cells/ml) exponentially growing cells
were transiently exposed to both Amp and fY83C toxin action for
120 min the survival rates of mazF+ and DmazF cells were similar
(Table 1). Together these data suggested that under the conditions
used, the potential activation of MazF (by fY83C induction of
[p]ppGpp synthesis) did not contribute to the increased sensitiza-
tion to Amp in the presence of fY83C toxin (Table 1). It is likely
that the second hypothesis (see above) might not apply upon
fY83C toxin expression, at least with the antimicrobials used,
because the presence or absence the host-encoded mazF and
fY83C toxin marginally contribute to persistence.
Expression of fY83C toxin sensitizes non-growing cells to
antimicrobials
To learn whether nutrient limitation prior to fY83C expression
or the non-growth condition could affect the level of tolerance,
high-density (,16109 cells/ml) or low-density (,16106 cells/ml)
stationary phase B. subtilis cells were analyzed. An overnight
culture of BG689 cells grown in MMS7 was washed with fresh,
pre-warmed MMS7, and resuspended to ,16109 cells/ml, and
then exposed to 0.5% Xyl for 120 or 240 min to induce fY83C
toxin expression (Figure 2A and 2B). Expression of the fY83C
toxin under these growth conditions rendered a subpopulation of
Figure 4. RelA is required for fY83C toxin enhanced efficacy to different antimicrobials. A) BG1145 cells (DrelA) were grown to ,56107
cells/ml. Then 0.5% Xyl and/or an AM were added and the cultures were incubated for 120 min. B) BG1145 cells were pre-treated with limiting relacin
(1 mM) concentrations (+ Rel) or not (2 Rel), and then 0.5% Xyl, Amp or both were added and the cultures were incubated for 120 min. The symbols,
the plating conditions, and the antimicrobial concentrations were those indicated in Figure 1. Error bars show 95% confidence intervals of more than
three independent experiments.
doi:10.1371/journal.pone.0086615.g004
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cells tolerant of fY83C toxin action (2–661024 survivals,
Figure 2A and 2B), which is 5- to 10-times more tolerant of toxin
action when compared to moderate-density exponentially growing
cells (Figure 1A and 1B). The nature of f toxin tolerance in high-
density stationary phase cells is unknown. Under this condition,
the expression of host-encoded toxins (e.g., RtbD, RtbG, RtbI,
RtbL, RtbN and/or SpoIISA) [40] and/or production of natural
antimicrobials [41] could contribute to f toxin tolerance.
Alternatively, in stationary phase low levels of translation could
reduce the levels of fY83C toxin. To test this hypothesis an
overnight culture of BG689 cells was washed with fresh, pre-
warmed MMS7, resuspended to ,16106 cells/ml, and then
exposed to 0.5% Xyl for 120 or 240 min to induce fY83C toxin
expression (Figure 2C and 2D). Expression of the toxin
significantly reduced the tolerant fraction (6–861025 survivals)
to levels comparable to moderate-density exponentially growing
BG689 cells (Figure 1A and 1B), suggesting that toxin expression
was marginally affected if at all in stationary phase, and that the
number of fY83C toxin tolerant cells does not depend on the
growth stage.
Transient addition of Amp, Cip or Tri to high-density slow- or
non-growing cells increased the rate of tolerance 100- to 106-fold
after 120 or 240 min (Figure 2A and 2B) in comparison with
exponentially growing moderate-density cells (Figure 1A and 1B).
Figure 5. Optimal levels of (p)ppGpp and GTP (GDP) are required for fY83C and antimicrobial tolerance. A) BG1202 (relA+), BG1203
(DrelA) or BG1213 (DrelA DsasA DsasB) cells were grown in MMS7 to ,56107 cells/ml, then 0.5% Xyl and/or Amp were added and the cultures
incubated for 120 min. Appropriate dilutions were then platted on LB agar. B), DrelA DsasB cells (BG 1209) were pre-treated with decoyinine (100 mg/
ml, + Dec) or not (2 Dec) for 30 min, and then 0.5% Xyl, Amp or both were added and the cultures were further incubated for 120 min. The symbols,
plating conditions, and antimicrobial concentrations were as described in Figure 1. Error bars show 95% confidence intervals of more than three
independent experiments.
doi:10.1371/journal.pone.0086615.g005
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It could be hypothesized that high-density non-growing cells may
have a heterogeneously increased frequency of pre-existing cells
refractory to the antimicrobial treatment (e.g., the antimicrobials
have their targets inactive, as might be the case upon Amp
addition). Alternatively, high-density non-growing cells may be
‘‘drug indifferent’’ because no correction by per-cell in the
antimicrobial concentration was performed. To address whether
this large increment in antimicrobial-tolerance observed with high-
density non-growing cells is an effect of lower per-cell antimicro-
bial concentration, stationary phase cells were diluted into fresh,
pre-warmed MMS7 medium to ,16106 cells/ml. The subpop-
ulation of low-density non-growing cells persistant of transient
exposure to an antimicrobial (Figure 2C and 2D) was smaller than
in high-density non-growing cultures (Figure 2A and 2B), and
more similar to moderate-density exponentially growing cells (see
Figure 1A and 1B). It is likely that the dramatic increase in
tolerance (up to 1000-fold) to antimicrobials (except Ery) in high-
density non-growing cells might not be attributable to the
refractoriness of high-density non-growing cells to antimicrobials,
and it might reflect a per-cell antimicrobial concentration. It is
worth mentioning that MICs were estimated using low-density
cells (1 to 36106 cells/ml for 16 h, at 37uC).
In stationary phase E. coli cells, HipA7 (over)expression exhibits
an elevated survival rate (100- to 10,000-fold) upon Amp addition
in non- or extremely slow-growing cells [3,5,6]. We addressed
whether low-density growth-arrested cells expressing the f toxin
became more tolerant of antimicrobials. Expression of the fY83C
toxin and addition of Amp, Ery, Cip or Tri significantly reduced
the persistant fraction (161024–761025 survivals) of low-density
stationary phase cells (Figure 2C and 2D) to levels comparable to
moderate-density exponentially growing BG689 cells (Figure 1A
and 1B). It is likely that first hypothesis (see above) might not apply
upon fY83C toxin expression, at least with the antimicrobials
used, because in growth-arrested cells at the time of exposure to
the antimicrobials the targets were not inactive.
Antitoxin e2 only reverses the effect of f in exponential or
stationary phase cells exposed to antimicrobials
To rule out any specific contribution of the Y83C mutation in f
toxin action, and to test whether the exit of dormancy, by
expression of the e2 antitoxin, contributes to antimicrobial
sensitivity, the effect of induction of the long-living wt f toxin, at
or near physiological concentrations (1,700 monomers/cell) (see
Materials and methods), for 120 or 240 min, in exponentially
moderate-density growing cells (,56107 cells/ml) was analyzed.
Here, wt f toxin expression was induced by addition of 1 mM
IPTG, and e2 antitoxin expression by 0.5% Xyl addition. The
plasmid-borne e gene (pCB799) confers resistance to Ery, thus the
analysis of this antimicrobial was omitted [20].
Expression of f toxin for 120 or 240 min induced dormancy of
the cell population, and a fraction was tolerant of f toxin action
(,461025) (Figure 3A and 3B, ‘‘No AM’’). Subsequent expression
of the e2 antitoxin, upon plating on LB agar containing 0.5% Xyl,
led to partial exit of the dormant state, and CFUs increased,250-
fold (Figure 3A and 3B, ‘‘No AM’’). Alternatively the levels of e2
antitoxin expression were not sufficient to overcome the effect of
the wt f toxin. A full recovery was only observed in cells that were
incubated with 0.5% Xyl for 120 min before plating in the
presence of Xyl (see [20]). When the toxin tolerance of this strain
was compared with the fY83C strain, it was observed that the rate
of survivals upon antimicrobial treatment was 2- to 6-fold lower in
the former (Figure 3A) than in the latter strain (Figure 1A),
suggesting that the leakage of the Phsp promoter or the longer half-
life of the wt f toxin might contribute to reducing the survival
fraction.
The transient addition of Amp, Cip or Tri decreased colony
formation rendering 861024 to 361027 survivals after 120 min
(Figure 3A). Similar rate of survivals were observed for cells only
treated with the antimicrobial, and for cells treated with both
antimicrobials and toxin and then induced e2 antitoxin expression,
suggesting that the e2 antitoxin only reversed the toxin action.
Expression of f toxin markedly decreased the antimicrobial
tolerant fraction to the limit of detection (Figure 3A and 3B),
suggesting that the exposure to both, an antimicrobial and f toxin,
markedly increased the efficacy of the antimicrobials, leading to
MDS.
To test whether expression of e2 antitoxin also reversed the
effect of f-mediated dormancy in high-density non-growing cells,
early stationary phase BG1125 cells (,16109 cells/ml) were
analyzed. Expression of f toxin induced dormancy of the cell
population, but a fraction of high-density cells was tolerant
(,261025) to f toxin action (Figure 3C and 3D), which is a value
similar to the one obtained in exponential growth. Expression of f
toxin and treatment with Cip (Figure 3C and 3D) and Tri (data
not shown) significantly reduced CFU of BG1125 cells, leading to
MDS. The expression of e2 antitoxin reversed the effect of the f
toxin (Figure 3C and 3D). It is likely that: i) f toxin induces a
reversible dormant state rather than cell killing; ii) there are many
distinct subpopulations of tolerant cells (Figure 3); and iii) toxin
and antimicrobial tolerants are different subpopulations of cells,
because expression of e2 antitoxin reversed only the effect of the f
toxin.
The absence of RelA enhances tolerance to both fY83C
and an antimicrobial
In bacteria, one rapid and sophisticated response to nutrient
limitation is the accumulation of (p)ppGpp, which induces a global
response to environmental stress, and is the major determinant of
growth rate control [24]. The cellular response to f toxin
Table 1. Effect of a chromosomal-encoded TA locus on the
formation of antimicrobial persisters.
strain Conditions Toxinc CFUs/mld
mazF+ 2 Xyl fY83C2 2.26108
mazF+ + Xyla fY83C+ 2.36103
mazF+ + Ampb fY83C2 4.56105
mazF+ + Xyla+Ampb fY83C+ 4.46102
DmazF 2 Xyl fY83C2 2.46108
DmazF + Xyla fY83C+ 2.86103
DmazF + Ampb fY83C2 9.06105
DmazF + Xyla+Ampb fY83C+ 4.66102
BG689 (fY83C mazF+) and BG1243 (fY83C DmazF) cells were grown in MMS7 to
,56107 cell ml21. Then 0.5% Xyla or 2x-MIC Ampb or both was added and the
culture was incubated for 120 min.
cInduction or not of the fY83C toxin is indicated by + and 2 superscript
symbols, respectively.
dThe CFUs were measured after 120 min of toxin induction and/or antimicrobial
addition by plating appropriate dilutions on LB plates. The results are the
average of at least three independent experiments and are within a 10%
standard error.
doi:10.1371/journal.pone.0086615.t001
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expression resembles the nutrient starvation response, since toxin
expression inhibits DNA, RNA and phospholipid synthesis,
decreases the ATP and GTP pools, and increases (p)ppGpp
[20]. Hyper-tolerance to f toxin action was observed in B. subtilis
DrelA cells that lack the major (p)ppGpp synthase [20]. Similarly,
vancomycin hyper-tolerance is observed in Enterococcus faecalis DrelA
cells [42]. Conversely, in E. coli cells high levels of hipA7 diminished
the levels of persistence in DrelA cells when compared to the wt
context [21,22,43]. How can we rationalize this apparent
contradiction? In Firmicutes the intracellular levels of (p)ppGpp
are maintained by the bifunctional RelA, which both synthesizes
and degrades (p)ppGpp in response to the cellular nutritional
status, and by one or two secondary monofunctional synthases
(SasA and SasB) (SI Annex S1 in file S1) [27,28,44]. The role of
these monofunctional synthases is to fine-tune any downward
levels of (p)ppGpp during homeostatic growth of wt cells (SI Annex
S1 in file S1, Figure S1 in file S2) [20,25,27–29,44], so that in the
DrelA context, there are ‘‘dysregulated or uncontrolled’’ low
undetectable (p)ppGpp levels [27,28] because there is a low
continuous (p)ppGpp synthesis, by the contribution of the SasA
and SasB synthases, that cannot be hydrolyzed in the absence of
RelA (see SI Annex S1 in file S1).
To test whether these ‘‘uncontrolled’’ basal (p)ppGpp levels
might contribute also to antimicrobial hyper-tolerance we
analyzed the effect of different antimicrobials in the presence or
absence of toxin expression in the DrelA context (Figure 4).
Exponentially growing ,56107 DrelA cells/ml were treated with
Xyl or transiently exposed to different antimicrobials. As
previously observed, the absence of RelA rendered exponentially
growing cells ,100-fold more tolerant of fY83C toxin action
(hyper-tolerance) (Figure 4A and S3A) when compared to relA+
cells (Figure 1). After transient exposure to Amp-, Cip- or Tri-
treatment for 120 or 240 min, the surviving fraction (,261021 to
,461024, Figure 4A and S3A) was markedly increased when
compared to the survival rate observed in relA+ cells (,261022 to
,461027) (Figure 1A). Expression of f toxin and treatment with
the different antimicrobials reduced CFU to levels comparable to
toxin alone (Figure 4A and Figure S3A in file S2).
When high-density non-growing DrelA cells (,16109 cells/ml)
were transiently exposed to both fY83C toxin and any of the
antimicrobials, the rate of non-inheritable tolerance increased
1,000- to 5,000-fold (Figure S3B and S3C in file S2) when
compared to high-density non-growing relA+ cells (Figure 2A and
2B). These results suggest that the DrelA mutation confers a MDT
phenotype. In contrast, (p)ppGpp accumulation correlates with
AM persistance in proteobacteria (SI Annex S1 in file S1), and
overexpression of the HipA7 toxin facilitates the development of
Amp persisters through the production of (p)ppGpp [21,22]. It was
reported that the stringent response in P. aeruginosa facilitates
persister formation in stationary phase cells by controlling the
levels of reactive oxygen species [31,45], raising the hypothesis that
persistence depends on factors that regulate the lethal effect of
reactive oxygen species. Unlike in P. aeruginosa cells, reactive
oxygen species do not contribute to f toxin tolerance (SI Annex S1
in file S1).
General stress response does not contribute to
antimicrobial tolerance
Toxin and antimicrobial hyper-tolerance, in the DrelA context,
can also be attributed to the absence of the general stress response,
because the strain used is impaired in sigB expression, and lacks the
active sB general stress response regulator (SI Annex S2 in file S1).
To test this hypothesis, we constructed a new set of strains in a
sigB+ background (Table S1 in file S2). A similar outcome to toxin
and antimicrobial tolerance was observed when the DrelA sigB2
and DrelA sigB+ strains were compared (see Figure 4A and 5A),
suggesting that the general stress response does not seem to be
involved in toxin and antimicrobial hyper-tolerance. It is likely
that the third hypothesis (see above) might not apply upon fY83C
toxin expression, at least with the antimicrobials used, because in
the absence of stringent response (DrelA sigB+) or general stress
response (DrelA sigB2) hyper-tolerant cells were observed.
Artificial reduction of (p)ppGpp levels decreases
antimicrobial hyper-tolerance
It has been observed that the poor growth phenotype of relA
cells can be suppressed by further decreasing the (p)ppGpp levels
by impairment of the synthase domain of the bifunctional
synthase-hydrolase RelA, or by the deletion of the SasB and/or
SasA synthases [27,28]. We hypothesized that ‘‘dysregulated’’
basal levels of (p)ppGpp by its ‘‘uncontrolled’’ synthesis by the
SasA and/or SasB synthases might contribute to toxin and
antimicrobial hyper-tolerance (see Figure 4A). To test this
hypothesis we have taken advantage of relacin [46]. Relacin is a
novel ppGpp analogue that poisons the active center of the
(p)ppGpp synthases in vitro, and reduces (p)ppGpp production in B.
subtilis cells in vivo [46]. To evaluate whether the decrease of
(p)ppGpp levels in the DrelA context reduces the level of hyper-
tolerance of toxin or antimicrobials, exponentially growing cells
were pre-treated with a limited relacin concentration (1 mM) that
shows no apparent effect on the proliferation of wt cells. When the
cells reached ,56107 cells/ml, 0.5% Xyl and/or Amp were
added and the proportion of surviving cells after 120 min was
analyzed (Figure 4B). When DrelA cells were pre-treated with
relacin the surviving fraction of toxin, Amp or both treated
cultures significantly decreased to levels comparable to relA+ cells
(compare Figure 1A and 4B). It is likely that: i) transient addition
of relacin is sufficient to overcome the hyper-tolerance phenotype
observed in the DrelA context; ii) relacin might interact with the
active center of SasA and/or SasB synthases and poison (p)ppGpp
production; and iii) an artificial decrease in basal (p)ppGpp levels is
sufficient to overcome the hyper-tolerance phenotype observed in
the DrelA context.
Reduction of basal (p)ppGpp levels contributes to
reducing antimicrobial hyper-tolerance
To test the contribution of each synthase toward the dysreg-
ulated low undetectable (p)ppGpp levels responsible for toxin and
antimicrobial hyper-tolerance, strains lacking one or more
synthases in a sigB+ background were constructed and analyzed.
Moderate-density exponentially growing DrelA, DsasA, DsasB,
DsasA DsasB, DrelA DsasB, DrelA DsasA and DrelA DsasA DsasB
(,56107 cells/ml) cells were transiently exposed to Xyl, Amp or
both for 120 min and the rate of tolerance analyzed (Figure 5A,
5B and S4). Three different outcomes were observed. First, an
increased phenotypic hyper-tolerance to the toxin or to the
antimicrobial or to both was observed in the DrelA context
(Figure 5A). Second, in the absence of SasA or RelA and SasA an
intermediate phenotype was observed (Figure S4 in file S2). Here,
the cells were slightly more tolerant of the toxin or Amp than wt
cells, but less tolerant that in the DrelA context. Third, in the
absence of RelA and SasB or RelA, SasA and SasB a significant
decrease in toxin and Amp tolerance was observed (Figure 5A and
5B), confirming that the absence of RelA alone is not involved in
toxin and antimicrobial hyper-tolerance. It is likely that (p)ppGpp
synthesized by SasB, and in minor extent by SasA, contributes to
hyper-tolerance in the relA context. Conversely, in Proteobacteria
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(e.g., E. coli and P. aeruginosa) dysregulated high (p)ppGpp levels lead
to hyper-tolerance [31,47–49]. In E. coli cells, artificial overex-
pression of the relA gene or in the spoT1 context (with attenuated
hydrolase activity), lead to high dysregulated (p)ppGpp levels and
hyper-tolerance [48,49].
Dysfunction of GTP homeostasis contributes to
eradicating antimicrobial tolerance
In the presence of low (p)ppGpp (DrelA DsasB) or in its absence,
([p]ppGpp0, DrelA DsasA DsasB), GTP levels increase (Figure S1 in
file S2) [28,44]. Since the intracellular GTP pool is markedly
increased in the DrelA DsasB or DrelA DsasA DsasB context, even in
the presence of fY83C toxin expression (Figure S1 in file S2, our
unpublished results), we hypothesized that it is the dysregulation of
the GTP pool that could lead to the observed lethality upon
exposure to the toxin and Amp (see SI Annex S1 in file S1). To test
this hypothesis (see [44]), we artificially lowered the GTP pool by
addition of decoyinine, which is a GMP synthetase inhibitor
[44,50]. Exponentially growing DsasB DrelA cells were pre-treated
with decoyinine (100 mg/ml), and when the cells reached
moderate-density, ,56107 cells/ml, toxin expression was induced
and/or Amp was added, and survival was analyzed 120 min later
(Figure 5B).
The artificial reduction of the GTP (or GDP) levels by the
transient addition of decoyinine increased the rate of survival of
DsasB DsasA DrelA ([p]ppGpp0) and DsasB DrelA (low [p]ppGpp)
(Figure 5B, data not shown). However, when relA+ cells were
exposed to the transient addition of decoyinine, no significant
difference with the untreated control was observed [20]. It is likely
that the fourth hypothesis (see above) might apply upon fY83C
toxin expression, because cells have evolved mechanisms to survive
changing environments.
Conclusions
We report here that in the presence of antimicrobials with
different modes of action, f toxin expression, independently of the
growth phase and the growth rate, alters the physiological
mechanisms used by the cells to evade antimicrobial lethality
and potentiates cell killing in wt context. Subsequent expression of
the e2 antitoxin specifically reverses f-induced dormancy, but not
the persistence of the different antimicrobials, suggesting the
presence of different subpopulations of tolerant cells. The use of wt
f-GFP or inactive fK46A-GFP fused variants (see [19]), in a follow
up study could shed more light on the presence of these proposed
subpopulations.
Different antimicrobials trigger specific responses that might
have adaptive values [51], and antimicrobial tolerance is due to
many different mechanisms [52]. The molecular mechanism of
tolerance might differ between bacteria of the c-Proteobacteria
class and those of the Firmicutes phylum due to differences in their
cellular metabolism. In the former bacterial class, the monofunc-
tional RelA synthase is required for persistence, (p)ppGpp
functions as a signal that determines whether single cells
differentiate into a persistent state, and the persistence level
increases in the presence of high uncontrolled (p)ppGpp levels
[31,47–49]. In bacteria of the Firmicutes phylum, inactivation of
the bifunctional RelA synthase, and the presence of low
uncontrolled (p)ppGpp levels leads to hyper-tolerance of toxin
and/or of antimicrobials (Figure 4 and 5). It is likely that (p)ppGpp
homeostasis contributes to persistence, but E. coli and B. subtilis
cells use (p)ppGpp in different ways to survive starvation and the
mode of action of these secondary messengers is significantly
different between E. coli [48,49] and B. subtilis (this work) [20]. In
B. subtilis, (p)ppGpp directly regulates GTP homeostasis and GTP
levels are critical for fitness (Fig. 5) [44]. The interplay between f-
induced dormancy and the regulation of the (p)ppGpp and GTP
levels can provide a rational to understand the molecular
mechanisms of antimicrobial tolerance in Firmicutes. The active
response to nutrient limitation, or increased (p)ppGpp and
decreased GTP levels by f toxin expression, does not increase
accumulation of tolerant cells [20]. Toxin-induced and host-
controlled subtle changes in the threshold levels of (p)ppGpp and
GTP, lead to three different outcomes: hyper-tolerance in DrelA
cells, normal tolerance in the wt and DsasA DsasB backgrounds,
and increased cell death in the DrelA DsasB or DrelA DsasA DsasB
context upon toxin expression or antimicrobial addition (SI Annex
S1 in file S1, Figure S1 in file S2).
Is the active response to starvation different in the different
bacterial genera? In E. coli (the best-characterized representative
from the c-Proteobacteria class) a mutant equivalent to B. subtilis
DrelA, which should be defective in the bifunctional synthase-
hydrolase (E. coli SpoT) and proficient in the monofunctional
synthase (E. coli RelA), was not viable [53]. In contrast, deletion of
spoT did not cause a lethal phenotype in P. aeruginosa (another
species of the c-Proteobacteria class). Here, ‘‘dysregulation’’ of the
(p)ppGpp levels, by lack of the hydrolase activity, renders high
(p)ppGpp levels and cells hyper-tolerant of Cip [47]. Similarly,
high unregulated (p)ppGpp levels, by artificial overexpression of
the RelA gene or in the spoT1 context (attenuated hydrolase
activity), lead to hyper-tolerance in E. coli cells [48]. Conversely, in
B. subtilis DrelA cells hyper-tolerance to f toxin and to different
antimicrobials is observed in the presence of undetectable
‘‘dysregulated’’ (p)ppGpp levels. Similarly, vancomycin hyper-
tolerance is enhanced in Enterococcus faecalis DrelA cells (SI Annex S1
in file S1) [42]. This hyper-tolerant phenotype can be partially
reversed by inactivation of either the SasA or the SasB synthase
(Figure 5 and Figure S4) or artificial reduction of the (p)ppGpp
pool by the presence of limiting relacin concentrations (Figure 4B).
This finding, which underscores an all-or-nothing phenomenon,
was ascribed to an imbalance of the (p)ppGpp pools.
A manifest loss of viability by the combined action of an
antimicrobial and the toxin was observed in the presence of low
(p)ppGpp or (p)ppGpp0 with a concomitant increase in GTP levels
(Figure 5 and Figure S1 in file S2). An artificial decrease in de novo
GTP synthesis in the presence of decoyinine, however, signifi-
cantly decreases the sensitivity of the cells to the action of the f
toxin or an antimicrobial in the DrelA DsasB context (Figure 5B).
Similar results were observed in the (p)ppGpp0 background (data
not shown). The mechanism underlying cell death by an elevated
GTP level remains poorly understood (see [44]), but we show here
that this contributes to death by different antimicrobials and f
toxin. The rheostat control of (p)ppGpp and GTP warrants further
investigation at the genetic and biochemical levels, because it is
conceivable that by modulating (p)ppGpp levels, as a new
therapeutic strategy, we might inadvertently increase the burden
of nosocomial infections, as in the absence of RelA, before
attaining cell killing as in the (p)ppGpp0 context.
Supporting Information
File S1 Annex S1. The alarmone (p)ppGpp mediates stress
responses and controls toxin and antimicrobial tolerance in
Firmicutes. Annex S2 General stress response is not involved in
toxin and antimicrobial tolerance.
(DOCX)
File S2 Figure S1. Schematic diagrams showing the pathway
for stringent response in different genetic backgrounds of B. subtilis.
The stringent control is induced in response to a number of
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stresses, and then the alarmone synthases synthesize (p)ppGpp by
phosphorylation of GTP (GDP) in the presence of ATP. In
response to stress by amino acid starvation (e.g., by addition of
arginine hydroxamate) the levels of (p)ppGpp transiently increase
.100-fold and the GTP pool decreases 50- to 60 fold in the wt or
sasA sasB context [20,25,26–28]. Accumulation of (p)ppGpp
produces transient and reversible inhibition of GTPases (e.g.
Obg), affects nucleotide and lipid metabolism, etc., and causes a
halt in cell proliferation, by inhibiting DNA replication (DnaG),
and normal tolerance to antimicrobial and to the f toxin. Cells exit
the growth arrest upon reallocation of resources. In the relA
context, the uncontrolled undetectable levels of (p)ppGpp lead to
poor stress survival, but to antimicrobial and f toxin hyper-
tolerance (see Figure 4). Toxin expression and Amp addition
decrease the survival rate of DsasA DsasB DrelA cells and to a minor
extent of sasB DrelA cells, and this effect is partially overcome when
GTP synthesis is inhibited by decoyinine addition, suggesting that
low GTP levels are necessary for tolerance. aND, not detected,
assigned an arbitrary value of,1 in the wt unstressed context (10–
20 mM), and increased to 1–3 mM after 10 min exposure to
arginine hydroxamate [25,26,27,28,44]. bThe GTP levels are
given relative to the values in the wt strain under unstressed
conditions (,5 mM), which are denoted by an arbitrary value of
100, and decreased to 80–100 mM after 10 min exposure to
arginine hydroxamate [28,44,54]. cIn the absence of RelA, the
addition of branched chain amino acids was required for cell
growth. Figure S2. Efficacy of ampicillin and ciprofloxacin during
exponential growth. BG689 cells were grown in MMS7 at 37uC
up to,56107 cells/ml, then Amp, Cip or both antimicrobial were
added. The cultures were incubated for 120 min and then plated
onto LB agar plates. The symbols, the plating conditions, and the
antimicrobial concentrations were those indicated in Figure 1. The
number of CFUs relative to the non-induced/non-AM treated
control is shown. Error bars show 95% confidence intervals of
more than three independent experiments. (TIF). Figure S3 RelA
is required for fY83C toxin enhanced efficacy to different
antimicrobials. BG1145 (DrelA)-borne fY83C gene was induced
by the addition of 0.5% Xyl. BG1145 cells were grown to,56107
cells/ml in MMS7. Then 0.5% Xyl and/or an antimicrobial were
added, and the cultures were incubated for 240 min with agitation
at 37uC (A). BG1145 cells were grown to early stationary phase
and diluted into fresh pre-warmed MMS7 to ,16109 cells/ml.
Then 0.5% Xyl and/or an antimicrobial were added to these
high-density non-growing cells, and the cultures were incubated
for 120 min (B) or 240 min (C) with agitation at 37uC.
Appropriated dilutions were then plated on LB agar, and
incubated for 36 h at 37uC. The symbols, the plating conditions,
and the antimicrobial concentrations were those indicated in
Figure 1. Error bars show 95% confidence intervals of more than
three independent experiments. Figure S4 Variations in the levels
of (p)ppGpp alter the outcome of fY83C- tolerance and Amp
persistence. BG1205 (DsasA), BG1207 (DsasB), BG1211 (DsasA
DsasB) or BG1301 (DrelA DsasA) cells were grown in MMS7 to
,56107 cells/ml, then 0.5% Xyl and/or Amp was added and the
cultures were incubated for 120 min. Appropriate dilutions were
then plated on LB agar and incubated for 36 h at 37uC. The
symbols, the plating conditions, and the antimicrobial concentra-
tions were those indicated in Figure 1. Error bars show 95%
confidence intervals of more than three independent experiments.
Table S1. Bacterial strains used.
(PDF)
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